Etoricoxib
Etoricoxib (Arcoxia, MK-663, MK-0663, Tauxib, Algix, Nucoxia) is a new COX-2 selective inhibitor with anti-inflammatory, antipyretic, analgesic, and potential antineoplastic properties.
| Trivial name | Arcoxia, MK-663, MK-0663, Tauxib, Algix, Nucoxia |
| Catalog Number | S4651 |
| Molecular Formula | C20H16Cl2F3N3O4S |
| CAS# | 202409-33-4 |
| Inchi | InChI=1S/C20H16Cl2F3N3O4S/c21-10-2-1-9(5-11(10)22)33-20-19(31)17(18(30)15(7-29)32-20)28-6-14(26-27-28)8-3-12(23)16(25)13(24)4-8/h1-6,15,17-20,29-31H,7H2/t15-,17+,18+,19-,20-/m1/s1 |
| Inchi Key | CSGJIUAIYDKFPC-DABHTEOTSA-N |
| SMILES | OCC1OC(SC2=CC=C(Cl)C(=C2)Cl)C(O)C(C1O)[N]3C=C(N=N3)C4=CC(=C(F)C(=C4)F)F |
| Size | 100mg |
| Supplier Page | http://www.selleckchem.com/products/etoricoxib.html |
| Additional Information | https://file.selleck.cn/downloads/struct/etoricoxib-chemical-structure-s4651.gif |